Top Markets
Coin of the day
Stryker Corporation Stryker Corporation

Stryker Corporation

SYK
Rangering i aksjer #160
Stryker Corporation operates as a medical technology company. The company... Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Aksjekurs
$336.84
Markedsverdi
$129.13B
Endring (1 dag)
2.00%
Endring (1 år)
-15.94%
Land
US
Handel Stryker Corporation (SYK)

Kategori

P/E-forhold for Stryker Corporation (SYK)
P/E-forhold per July 2026 TTM: 35.63
Ifølge Stryker Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 35.63. Ved slutten av 2024 hadde selskapet en P/E på 45.83.
P/E-forholdshistorikk for Stryker Corporation fra 2000 til 2026
P/E-forhold ved slutten av hvert år
År P/E-forhold Endre
2026 (TTM) 35.63 -13.89%
2025 41.38 -9.71%
2024 45.83 27.61%
2023 35.92 -8.41%
2022 39.21 -22.44%
2021 50.56 -12.14%
2020 57.54 52.66%
2019 37.69 128.39%
2018 16.50 -70.93%
2017 56.77 108.63%
2016 27.21 11.88%
2015 24.32 -64.92%
2014 69.33 145.16%
2013 28.28 75.92%
2012 16.07 12.53%
2011 14.28 -14.55%
2010 16.72 -7.52%
2009 18.08 27.26%
2008 14.20 -52.79%
2007 30.09 4.28%
2006 28.85 8.62%
2005 26.56 -36.09%
2004 41.57 6.61%
2003 38.99 -3.57%
2002 40.43 -4.42%
2001 42.30 -5.53%
2000 44.78 0.00%
P/E-forhold for lignende selskaper eller konkurrenter
Selskap P/E-forhold Forskjell i P/E-forhold Land
24.71 -30.65%
US
21.15 -40.65%
IE
17.76 -50.15%
US
47.67 33.77%
US
30.88 -13.33%
US
Hvordan lese en P/E-ratio?

Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.

Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.

Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.